These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 8476722)
21. Prophylactic and therapeutic properties of a sodium citrate preparation in the management of calcium oxalate urolithiasis: randomized, placebo-controlled trial. Allie-Hamdulay S; Rodgers AL Urol Res; 2005 May; 33(2):116-24. PubMed ID: 15871014 [TBL] [Abstract][Full Text] [Related]
22. Effect of calcium citrate supplementation on urinary calcium oxalate saturation in female stone formers: implications for prevention of osteoporosis. Levine BS; Rodman JS; Wienerman S; Bockman RS; Lane JM; Chapman DS Am J Clin Nutr; 1994 Oct; 60(4):592-6. PubMed ID: 8092096 [TBL] [Abstract][Full Text] [Related]
23. [Effect of urine alkalization on excretion of renal citrate and degree of urine saturation with calcium oxalate in patients with calcium-oxalate urolithiasis and in healthy subjects]. Boruczkowska A Pol Arch Med Wewn; 1994 Feb; 91(2):77-83. PubMed ID: 8008619 [TBL] [Abstract][Full Text] [Related]
24. The role of hyperoxaluria in the formation of calcium oxalate urinary calculi, and its association with other biochemical measurements. Grases F; Conte A; Coll R; Genestar C Scand J Urol Nephrol; 1990; 24(3):211-3. PubMed ID: 2237298 [TBL] [Abstract][Full Text] [Related]
25. [Studies of citrate metabolism in urolithiasis. 2--Influences of citrate compound administration on sequential excretion of urinary citrate and other substances related to stone formation in healthy controls]. Yasukawa S; Uehara M; Morimoto S; Yoshida T; Fukatani T; Ebisuno S; Ohkawa T Nihon Hinyokika Gakkai Zasshi; 1987 Apr; 78(4):626-33. PubMed ID: 3669471 [No Abstract] [Full Text] [Related]
26. Urinary response to oral potassium citrate therapy for urolithiasis in a private practice setting. Nicar MJ; Hsu MC; Fetner C Clin Ther; 1986; 8(2):219-25. PubMed ID: 3698069 [TBL] [Abstract][Full Text] [Related]
27. Alkaline citrate in prevention of recurrent calcium oxalate stones. Berg C Scand J Urol Nephrol Suppl; 1990; 130():1-83. PubMed ID: 2291093 [TBL] [Abstract][Full Text] [Related]
28. Successful treatment of hyperuricosuric calcium oxalate nephrolithiasis with potassium citrate. Pak CY; Peterson R Arch Intern Med; 1986 May; 146(5):863-7. PubMed ID: 3963975 [TBL] [Abstract][Full Text] [Related]
29. Changes in urinary parameters after oral administration of potassium-sodium citrate and magnesium oxide to prevent urolithiasis. Kato Y; Yamaguchi S; Yachiku S; Nakazono S; Hori J; Wada N; Hou K Urology; 2004 Jan; 63(1):7-11; discussion 11-2. PubMed ID: 14751336 [TBL] [Abstract][Full Text] [Related]
30. Reduction of renal stone risk by potassium-magnesium citrate during 5 weeks of bed rest. Zerwekh JE; Odvina CV; Wuermser LA; Pak CY J Urol; 2007 Jun; 177(6):2179-84. PubMed ID: 17509313 [TBL] [Abstract][Full Text] [Related]
31. Limited risk of kidney stone formation during long-term calcium citrate supplementation in nonstone forming subjects. Sakhaee K; Baker S; Zerwekh J; Poindexter J; Garcia-Hernandez PA; Pak CY J Urol; 1994 Aug; 152(2 Pt 1):324-7. PubMed ID: 8015062 [TBL] [Abstract][Full Text] [Related]
32. [Estimation of 24-h excretion of some promotors and inhibitors of crystallization and degree of urine saturation with calcium oxalate in calcium urinary calculi]. Boruczkowska A Pol Arch Med Wewn; 1994 Oct; 92(4):289-98. PubMed ID: 7854956 [TBL] [Abstract][Full Text] [Related]
33. [Effect of cocoa on excretion of oxalate, citrate, magnesium and calcium in the urine of children]. Lagemann M; Anders D; Graef V; Bödeker RH Monatsschr Kinderheilkd; 1985 Oct; 133(10):754-9. PubMed ID: 4069117 [TBL] [Abstract][Full Text] [Related]
34. [Pathophysiology, diagnosis and conservative therapy in calcium kidney calculi]. Hess B Ther Umsch; 2003 Feb; 60(2):79-87. PubMed ID: 12649986 [TBL] [Abstract][Full Text] [Related]
35. Pyridoxamine lowers kidney crystals in experimental hyperoxaluria: a potential therapy for primary hyperoxaluria. Chetyrkin SV; Kim D; Belmont JM; Scheinman JI; Hudson BG; Voziyan PA Kidney Int; 2005 Jan; 67(1):53-60. PubMed ID: 15610227 [TBL] [Abstract][Full Text] [Related]
36. Effects of sodium citrate, potassium citrate, and citric acid in preventing experimental calcium oxalate urolithiasis in rats. Ogawa Y; Tanaka T; Yamaguchi K; Morozumi M; Kitagawa R Hinyokika Kiyo; 1987 Nov; 33(11):1772-7. PubMed ID: 3445859 [TBL] [Abstract][Full Text] [Related]
37. Plasma calcium oxalate supersaturation in children with primary hyperoxaluria and end-stage renal failure. Hoppe B; Kemper MJ; Bökenkamp A; Portale AA; Cohn RA; Langman CB Kidney Int; 1999 Jul; 56(1):268-74. PubMed ID: 10411702 [TBL] [Abstract][Full Text] [Related]
38. Enteric hyperoxaluria secondary to small bowel resection: use of computer simulation to characterize urinary risk factors for stone formation and assess potential treatment protocols. Rodgers AL; Allie-Hamdulay S; Jackson GE; Sutton RA J Endourol; 2014 Aug; 28(8):985-94. PubMed ID: 24773381 [TBL] [Abstract][Full Text] [Related]
39. Malic acid supplementation increases urinary citrate excretion and urinary pH: implications for the potential treatment of calcium oxalate stone disease. Rodgers AL; Webber D; de Charmoy R; Jackson GE; Ravenscroft N J Endourol; 2014 Feb; 28(2):229-36. PubMed ID: 24059642 [TBL] [Abstract][Full Text] [Related]
40. (L)-2-oxothiazolidine-4-carboxylate in the treatment of primary hyperoxaluria type 1. Holmes RP; Assimos DG; Wilson DM; Milliner DS BJU Int; 2001 Dec; 88(9):858-62. PubMed ID: 11851603 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]